Search+Investment IdeasBrokerages back resilient largecaps despite costs, pricing pressure, and execution headwinds ahead.SynopsisBrokerages maintain a positive outlook on select large-cap pharmaceutical, automobile, and healthcare stocks, citing strong growth prospects and expansion plans. Despite near-term challenges like pricing pressure and rising costs, analysts are backing companies with robust margin profiles and clear growth visibility. Key recommendations include Sun Pharma, Eicher Motors, and Max Healthcare Institute.Brokerages remain selectively positive on key largecap names across pharmaceuticals, automobiles, and healthcare despite near-term headwinds linked to pricing pressure, rising costs, and execution delays.Analysts continue to back companies with strong growth visibility, robust expansion plans, and improving margin profiles.While Elara Securities highlighted the strength of Sun Pharmaceutical Industries’ specialty business and the potential BYETMarkets.com 4 mins readMay 25, 2026, 09:56:00 AM ISTGift this Story to your friendsFONT SIZEAbcSmallAbcMediumAbcLargeSAVEPRINTCOMMENTContinue reading with one of these options:Limited AccessFreeLogin to get access to some exclusive stories & personalised newslettersLogin NowUnlimited AccessStarting @ Rs120/monthGet access to exclusive stories, expert opinions & in-depth stock reportsSubscribe NowETUh-oh! This is an exclusive story available for selected readers only.Worry not. You’re just a step away.What’s Included withETPrime Membership